# Inside RonanRx: Software-Driven Custom GLP-1 Manufacturing

> RonanRx is vertically integrating telehealth, software, and drug compounding to deliver personalized, affordable GLP-1 treatments.
- Title: Inside RonanRx: Software-Driven Custom GLP-1 Manufacturing
- Summary: RonanRx is vertically integrating telehealth, software, and drug compounding to deliver personalized, affordable GLP-1 treatments. Combining vertical…
- Keywords: biotech, startups, pharma, glp1, healthcare, technology, Inside, RonanRx, Software-Driven, Custom, GLP-1, Manufacturing
- Source: Hacker News — https://news.ycombinator.com/item?id=49543530
- Read time: 1 min
- Topics: biotech, startups, pharma, glp1, healthcare, technology
## From mask factories to medicine
After building a $50M automated mask manufacturing business during the pandemic, founder Lloyd Armbrust pivoted to solving disconnected pharmaceutical supply chains using software.

> We took a software approach to building our factory.
## The life-changing power of GLP-1s
Armbrust tried tirzepatide for weight loss and eliminated compulsive behaviors. Most surprisingly, the drug delayed his required open-heart surgery by decades.

> After just 18 months using tirzepatide, my cardiologist’s began to think my surgery could be pushed back until I am 70 or 80.
## Fragmented healthcare creates rigid dosing
Traditional pharmaceuticals sell fixed doses despite patients processing drugs differently. Telehealth, prescribing, manufacturing, and delivery operate in isolated silos.

> GLP-1s come in a handful of predefined doses, but patients obviously aren't standardized.
## Owning the entire pharmaceutical stack
RonanRx unifies telehealth, prescribing, compounding, manufacturing, and delivery into a single software-driven system.

> The thing that bothered me was how disconnected all of the pieces were: telehealth, EHR, prescriptions, dispensing software, production, shipping.
## A weekly feedback loop for dosing
By integrating wearable data, lab results, and patient side-effect logs, physicians can dynamically adjust custom micro-doses every week.

> As the patient is undergoing treatment, their response becomes data that can be used by their doctor to modify the treatment.
## Making GLP-1s dramatically more affordable
Starting from raw active molecules and manufacturing drugs in-house cuts out middlemen, reducing prices by 3x to 10x compared to traditional brand-name sources.

> Because people can buy directly from us, their price is usually 3x-10x more affordable.
## Navigating compounding pharmacy laws
Federal 503a compounding pharmacy regulations protect custom formulations. Continuous clinician-led personalization ensures full regulatory compliance while tailoring dosages.

> The legal cutout that we have is on the personalization front, which is very well protected.
## The future of patient-specific drugs
Starting with weight-loss peptides is just the first phase. RonanRx aims to build scalable infrastructure for custom, patient-specific drug manufacturing across medicine.

> We are more interested in the potential of patient-specific pharmaceutical manufacturing.
## Key takeaway

Combining vertical manufacturing with real-time doctor feedback loops enables hyper-personalized, lower-cost pharmaceutical care.